Differences in coagulation and fibrinolytic markers of different TCM syndromes in patients with chronic kidney disease  

作　　者：LI Zhen 李臻(Dept Clin Lab,Longhua Hosp,Shanghai TCM Univ,Shanghai 200030)

机构地区：[1]Dept Clin Lab,Longhua Hosp,Shanghai TCM Univ,Shanghai 200030

出　　处：《China Medical Abstracts(Internal Medicine)》2021年第3期140-140,共1页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To analyze the differences between coagulation and fibrinolysis biomarkers in different TCM syndromes of chronic kidney disease(CKD),and to explore the changes of these indicators in the progression of disease,as well as to provide references for clinical diagnosis and treatment of TCM.

关 键 词：KIDNEY diagnosis TCM 

分 类 号：R277.5[医药卫生—中医学]